当前位置: 首页 > 医疗版 > 疾病专题 > 泌尿外科 > 肾脏 > 肾细胞癌
编号:10669724
肾细胞癌原癌基因mdm2产物的定量分析
http://www.100md.com 《中华实验外科杂志》 1999年第3期
肾细胞癌|预后|mdm2原癌基因,关键词:
肾细胞癌原癌基因mdm2产物的定量分析
肾细胞癌原癌基因mdm2产物的定量分析

     沈瑞雄 张绍增 马立 730050 兰州军区总医院泌尿外科 中华实验外科杂志 1999 0 16 3


    关键词:肾细胞癌;预后;mdm2原癌基因 期刊 zhsywkzz 0 论著 fur -->


    

摘要 目的 探讨肾细胞癌原癌基因mdm2产物表达量与细胞DNA含量及临床病理参数的关系。方法 采用流式免疫荧光技术对50例肾细胞癌DNA含量及mdm2蛋白表达进行定量分析。结果 23例mdm2蛋白阳性表达,mdm2表达量与DNA含量有关,与瘤体大小、分级、分期、预后无关。结论 mdm2蛋白表达与肾细胞癌的发生、发展有关,但尚不足以作为衡量预后的指标。

Quantitative analysis on the mdm2products in renal cell carcinoma

SHEN Ruixiong,ZHANG Shaozeng, MA Li.

    Department of Urology, General Hospital of Lanzhou Military Region, PLA Lanzhou 730050

Abstract Objective Toexplore the relationship between mdm2 protein expression and cell DNA content or clinicalpathological parameters in renal cell carcinoma. Methods Flowcytometric and immunofluorescence technique were used to quantitatively analyze the DNAcontent and mdm2 protein expression in renal cell carcinoma. Results Positiverate of mdm2 expression was found in 23 cases (46%). There was a correlation between mdm2expression and DNA contents, but the mdm2 expression was not related with clinical tumorsize, grade, and prognosis. Conclusion mdm2 protein expression wasrelated to the carcinogenesis and development of renal cell carcinoma, but could not beused as an indicator to evaluate the prognosis.

     ......


您现在查看是摘要页,全文长 10186 字符